The growing interest in potent weight management has led to considerable exploration into groundbreaking treatments. Lately , Retatrutide, a combined -action hormone and glucagon-like peptide-1 (GLP-1) receptor stimulator, has demonstrated encouraging results in medical trials, implying potential